Back to Top
Go Back
Journal Photo for Antioxidants and Redox Signaling
Peer reviewed only Open Access

Antioxidants and Redox Signaling (ARS)

Publisher : Mary Ann Liebert Inc
Medicine Biochemistry Molecular Biology
Claim Your Journal Get PRC Visit Website
e-ISSN 1557-7716
p-ISSN 1523-0864
Issue Frequency Continuously
Impact Factor 6.6
Est. Year 1999
Mobile 9147402100
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email cksen@iu.edu

Journal Descriptions

Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas. ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.

Antioxidants and Redox Signaling (ARS) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Medicine, Biochemistry, Molecular Biology, Cell Biology , Online or Print , Continuously Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1523-0864, E-ISSN: 1557-7716, Established: 1999, Impact Factor: 6.6
  • Does Not Provide Crossref DOI

  • Indexed in: Scopus, PubMed

  • Not indexed in WoS, DOAJ, UGC CARE

Indexing

Publications of ARS

Interleukin-33 Induces Neutrophil Extracellular Trap (NET) Formation and Macrophage Necroptosis via Enhancing Oxidative Stress and Secretion of Proath...
Kailash Jaiswal November, 2022
Interleukin-33 (IL-33) acts as an 'alarmin', and its role has been demonstrated in driving immune regulation and inflammation in many human diseases. However, the precise mechanism of action...